WW International, Inc. Announces Second Quarter 2024 Results

End of Period Subscribers of 3.8 million, including 81 thousand End of Period Clinical Subscribers Revenues of $202.1 million Gross margin of 67.9% Operating Income of $35.9 million; excluding the net impact of restructuring charges related to prior year restructuring plans, adjusted operating income of $37.9 million Provides update to full year fiscal 2024 guidance Announces 2024 Restructuring Plan that is expected to result in $100 million of annual run-rate cost savings related to strategic streamlining ...